Global Growth And Factors Of Defibrillators Market 2019
Subtitle: Defibrillators Market (Advanced Life Support, Automated External Defibrillators, Implantable Cardioverter Defibrillators, Wearable Defibrillators) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Publisher: Transparency Market Research
Published: Published Date: 2014-02-26
Place of publication: Albany,New York, USA
Language: eng
Number of pages: 123
Description: he global defibrillators market was valued at USD 9.3 billion in 2012 and is expected to grow at a CAGR of 6.2% from 2013 to 2019, to reach an estimated value of USD 14.2billion in 2019.

Browse Global Defibrillators Market Report with Full TOC at http://www.transparencymarketresearch.com/defibrillators-market.html

Defibrillator devices are used to treat life-threatening cardiac arrhythmias, particularly ventricular fibrillation and pulseless ventricular tachycardia. These devices provide an electrical shock, having energy 40 - 400 Joule, to the heart muscles which terminates the arrhythmia and restores the normal sinus rhythm in the heart. Since the defibrillator devices are very useful in preventing deaths due to sudden cardiac arrest (SCA), the large number of SCA incidences across the globe is the major driver for the growth of this market.

Growing incidences of cardiovascular diseases and disorders combined with aging of baby boomer population in the U.S. are contributing to the growth of the global defibrillators market.Furthermore, the market is more driven by demand from emerging countries from Asia-Pacific and the Middle-East. Increasing trend towards installations of AEDs at workplaces by businesses is expected to serve as a good opportunity for the growth of global defibrillators market.

The global defibrillators market has been segmented on the basis of product types, end-users and geographic regions. On the basis of defibrillator types, the market is divided into advanced life support (ALS) defibrillators, automated external defibrillators (AEDs), implantable cardioverter defibrillators (ICDs) and wearable defibrillators. In 2012, implantable defibrillator devices accounted for the largest share by revenue of the global defibrillators followed by ALS defibrillators.The global rise in the healthcare infrastructure which include state-of-the-art hospitals and ambulances equipped with advanced medical devices is seen as a driver for ALS defibrillator segment.

The report also provides market estimations for the end-users of defibrillator devices during the forecast period of 2013 to 2019. The market has been categorized on the basis of end-users into five major segments, namely, hospitals, home, public access, emergency medical services and business workplace. In 2012, the hospitals as an end-user category shared more than 90%of the global defibrillator market.Other segments which are expected to grow rapidly during the forecast period are public access and business workplace. The government initiatives for creating awareness about the usefulness of AEDs in SCA will be the crucial factor for the growth of this market. Although the FDA initiatives to tighten the AED approval process, through pre-market approval (PMA), are likely to impact the market negatively, the grace period implementing changes is considerable enough for manufacturers in the defibrillators market.

Geographically, North America is the largest market for defibrillator devices and is expected to retain its top position throughout the forecast period. The rising awareness about the SCA and defibrillators in the USA and Canada is contributing to overall growth of defibrillators market in the region. In addition, legislations requiring installation of AEDs for public access and 'Samaritan Laws' providing immunity to first responders are driving factors for the market.Europe was the second largest market for defibrillator devices in 2012. During the forecast period, 2013 to 2019, Asia-Pacific and Middle-East are expected to grow at a faster pace than North America and Europe owing to the large patient base, increasing incidences of cardiovascular diseases and rising per capita expenditure on healthcare. The strengthening of economies in the Asia-Pacific and the subsequent rise in the healthcare infrastructure are propelling the market for defibrillators in this region.
Table of contents: title: Chapter 1 Preface; title: 1.1 Report Description; title: 1.2 Research Methodology; title: 1.3 Market Segmentation; title: 1.4 List of Abbreviations; title: Chapter 2 Executive Summary; title: Chapter 3 Global Defibrillators Market Overview; title: 3.1 Market Definition and Overview; title: 3.2 Drivers; title: 3.2.1 Increasing Cardiovascular Incidences; title: 3.2.2 Awareness Campaigns for AEDs; title: 3.2.3 Government Initiatives; title: 3.2.4 Technological Advancements; title: 3.3 Market Restraints; title: 3.3.1 Lack of Awareness about SCA and Legislations Globally; title: 3.3.2 Lack of ‘Product Design Criteria" to meet Requirements in Public Access; title: 3.3.3 Frequent Recalls of Defibrillator Products Leading to Confusion and Scepticism; title: 3.4 Market Opportunities; title: 3.4.1 Emerging Markets are Better Opportunity for Global Defibrillator Manufacturers; title: 3.5 Porter’s Five Forces Analysis: Global Defibrillators Market; title: 3.5.1 Bargaining Power of Suppliers; title: 3.5.2 Bargaining Power of Buyers; title: 3.5.3 Threat from New Entrants; title: 3.5.4 Threat from Substitutes; title: 3.5.5 Competitive Rivalry; title: 3.6 Market Attractiveness Analysis of the Global Defibrillators Market, By Geography; title: Chapter 4 Global Defibrillators Market, by Products, Size and Forecast, 2011 – 2019 Value (USD Million); title: 4.1 Introduction; title: 4.1.1 Global Defibrillators Market Revenue, by Product Type, 2011- 2019 (USD Million); title: 4.1.2 Comparative Analysis of the Global Defibrillators Market, by Product Type, 2012 & 2019 (%); title: 4.2 Advanced Life Support (ALS) Defibrillators; title: 4.2.1 Global Advanced Life Support Defibrillators Market Revenue, 2011-2019 (USD Million); title: 4.3 Automated External Defibrillators (AEDs); title: 4.3.1 Global Automated External Defibrillators Market Revenue, 2011-2019 (USD Million); title: 4.4 Implantable Cardioverter Defibrillators (ICD); title: 4.4.1 Global Implantable Cardioverter Defibrillators Market Revenue, 2011-2019 (USD Million); title: 4.5 Wearable Defibrillators; title: 4.5.1 Global Wearable Defibrillators Market Revenue, 2011-2019 (USD Million); title: Chapter 5 Global Defibrillators Market, by End Users, Size and Forecast, 2011 – 2019 Value (USD Million); title: 5.1 Introduction; title: 5.1.1 Global Defibrillator Devices Market, by End Users, 2011 – 2019 (USD Million); title: 5.2 Hospitals; title: 5.2.1 Global Hospital Defibrillators Market Revenue, 2011-2019 (USD Million); title: 5.3 Homes; title: 5.3.1 Global Home Defibrillators Market Revenue, 2011-2019 (USD Million); title: 5.4 Public Access Defibrillation; title: 5.4.1 Global Public Access Defibrillators Market Revenue, 2011-2019 (USD Million); title: 5.5 Emergency Medical Services; title: 5.5.1 Global Emergency Medical Services Defibrillators Market Revenue, 2011-2019 (USD Million); title: 5.6 Business Workplace; title: 5.6.1 Global Business Workplace Defibrillators Market Revenue, 2011-2019 (USD Million); title: Chapter 6 Global Defibrillators Market, by Geography, Size and Forecast, 2011 – 2019 Value (USD Million); title: 6.1 Introduction; title: 6.1.1 Global Defibrillators Market Revenue, by Geography, 2011 - 2019 (USD Million); title: 6.1.2 Comparative Analysis of the Global Defibrillators Market, by Geography, 2012 & 2019 (%); title: 6.2 North America; title: 6.2.1 North America Defibrillators Market Revenue, by Product Type, 2011- 2019 (USD Million); title: 6.2.2 North America Defibrillators Market Revenue, 2011-2019 (USD Million); title: 6.3 Europe; title: 6.3.1 Europe Defibrillators Market Revenue, by Product Type, 2011- 2019 (USD Million); title: 6.3.2 Europe Defibrillators Market Revenue, 2011-2019 (USD Million); title: 6.4 Asia Pacific; title: 6.4.1 Asia-Pacific Defibrillators Market Revenue, by Type, 2011 - 2019 (USD Million); title: 6.4.2 Asia-Pacific Defibrillators Market Revenue, 2011-2019 (USD Million); title: 6.5 Middle East; title: 6.5.1 Middle East Defibrillators Market Revenue, by Product Type, 2011- 2019 (USD Million); title: 6.5.2 Middle-East Defibrillators Market Revenue, 2011-2019 (USD Million); title: 6.6 Latin America; title: 6.6.1 Latin America Defibrillators Market Revenue, by Product Type, 2011- 2019 (USD Million); title: 6.6.2 Latin America Defibrillators Market Revenue, 2011-2019 (USD Million); title: 6.7 Africa; title: 6.7.1 Africa Defibrillators Market Revenue, by Product Type, 2011- 2019 (USD Million); title: 6.7.2 Africa Defibrillators Market Revenue, 2011-2019 (USD Million); title: Chapter 7 Competitive Landscape; title: 7.1 Market Share Analysis, by Key Players, 2012 (%); title: Chapter 8 Recommendations; title: 8.1 Recommendations; title: 8.1.1 Invest for Creating Public Awareness About Sudden Cardiac Arrest and Defibrillators; title: 8.1.2 Focus on AEDs at Business Workplace; title: 8.1.3 Expand Business in Emerging Markets: Asia-Pacific and Latin America.; title: 8.1.4 Continuous Product Development To Assure Safety And Efficacy; title: Chapter 9 Company Profiles; title: 9.1 BIOTRONIK SE & Co. KG; title: 9.1.1 Company Overview; title: 9.1.2 Product Portfolio; title: 9.1.3 Business Strategy; title: 9.1.4 Recent Developments; title: 9.2 Boston Scientific Corporation; title: 9.2.1 Company Overview; title: 9.2.2 Financial Overview; title: 9.2.3 Product Portfolio; title: 9.2.4 Business Strategies; title: 9.2.5 Recent Developments; title: 9.3 Defibtech, LLC; title: 9.3.1 Company Overview; title: 9.3.2 Financial Overview; title: 9.3.3 Product Portfolio; title: 9.3.4 Business Strategies; title: 9.3.5 Recent Developments; title: 9.4 GE HEALTHCARE; title: 9.4.1 Company Overview; title: 9.4.2 Financial Overview; title: 9.4.3 Product Portfolio; title: 9.4.4 Business Strategy; title: 9.4.5 Recent Developments; title: 9.5 HeartSine Technologies, Inc.; title: 9.5.1 Company Profile; title: 9.5.2 Financial Overview; title: 9.5.3 Product Portfolio; title: 9.5.4 Business Strategies; title: 9.5.5 Recent Developments; title: 9.6 M EDTRONIC, INC.; title: 9.6.1 Company Overview; title: 9.6.2 Financial Overview; title: 9.6.3 Product Portfolio; title: 9.6.4 Business Strategies; title: 9.6.5 Recent Developments; title: 9.7 Mindray Medical International Limited; title: 9.7.1 Company Overview; title: 9.7.2 Financial Overview; title: 9.7.3 Product Portfolio; title: 9.7.4 Business Strategies; title: 9.7.5 Recent Developments; title: 9.8 Nihon Kohden Corporation; title: 9.8.1 Company Overview; title: 9.8.2 Financial Overview; title: 9.8.3 Product Portfolio; title: 9.8.4 Business Strategies; title: 9.8.5 Recent Developments; title: 9.9 PHILIPS HEALTHCARE; title: 9.9.1 Company Overview; title: 9.9.2 Financial Overview; title: 9.9.3 Product Portfolio; title: 9.9.4 Business Strategies; title: 9.9.5 Recent Developments; title: 9.10 PHYSIO-CONTROL, INC.; title: 9.10.1 Company Overview; title: 9.10.2 Product Portfolio; title: 9.10.3 Business Strategies; title: 9.10.4 Recent Developments; title: 9.11 SCHILLER AG; title: 9.11.1 Company Overview; title: 9.11.2 Financial Overview; title: 9.11.3 Product Portfolio; title: 9.11.4 Business Strategies; title: 9.11.5 Recent Developments; title: 9.12 Sorin Group; title: 9.12.1 Company overview; title: 9.12.2 Financial Overview; title: 9.12.3 Product Portfolio; title: 9.12.4 Business strategies; title: 9.12.5 Recent Developments; title: 9.13 St. Jude Medical, Inc.; title: 9.13.1 Company Overview; title: 9.13.2 Financial Overview; title: 9.13.3 Product Portfolio; title: 9.13.4 Business Strategy; title: 9.13.5 Recent Developments; title: 9.14 ZOLL MEDICAL CORPORATION; title: 9.14.1 Company Overview; title: 9.14.2 Financial Overview; title: 9.14.3 Product Portfolio; title: 9.14.4 Business Strategy; title: 9.14.5 Recent Developments